Mengrong Miao

机构：Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou People's Hospital · ORCID：0000-0002-6956-8599

发表论文 83 篇 · 总被引 619 次 · h-index 14

代表论文

• Evaluating GLP-1 receptor agonists versus metformin as first-line therapy for reducing dementia risk in type 2 diabetes (2025 · BMJ Open Diabetes Research & Care · 被引 10)
• Metformin vs. second-line therapy for delirium prevention in type 2 diabetes: A multinational study (2025 · Diabetes Research and Clinical Practice · 被引 5)
• Association of propofol vs. sevoflurane maintenance anesthesia with postoperative delirium, cognitive decline, and mortality in older adults: a global comparative-effectiveness study (2026 · Critical Care · 被引 3)
• SGLT2is Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head- to-Head Comparative Study (2025 · Diabetes Care · 被引 3)
• Long‐term delirium and survival outcomes in patients treated with GLP ‐1 receptor agonists versus metformin in type 2 diabetes: A population‐based cohort study (2025 · Diabetes Obesity and Metabolism · 被引 3)
• SGLT2 inhibitors vs. metformin for Parkinson's disease risk reduction in type 2 diabetes (2025 · Journal of Parkinson s Disease · 被引 2)